DrugPatentWatch Database Preview
Drugs in MeSH Category Antibiotics, Antitubercular
» See Plans and Pricing
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Concord Biotech Ltd | MYCOPHENOLIC ACID | mycophenolic acid | TABLET, DELAYED RELEASE;ORAL | 211173-002 | Dec 13, 2019 | AB | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| Sanofi Aventis Us | RIFADIN | rifampin | CAPSULE;ORAL | 050420-001 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | |||
| Novartis | MYFORTIC | mycophenolic acid | TABLET, DELAYED RELEASE;ORAL | 050791-002 | Feb 27, 2004 | AB | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | |||
| Mylan | MYCOPHENOLIC ACID | mycophenolic acid | TABLET, DELAYED RELEASE;ORAL | 091248-002 | Jan 8, 2014 | AB | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
